BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15677540)

  • 1. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
    Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
    J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical appraisal of stromal CD10 staining in fibroepithelial lesions of breast with a special emphasis on expression patterns and correlation with WHO grading.
    Puri V; Jain M; Mahajan G; Pujani M
    J Cancer Res Ther; 2016; 12(2):667-70. PubMed ID: 27461629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
    Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
    J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
    Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
    Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
    Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
    Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phyllodes tumours of the breast - differentiating features in core needle biopsy.
    Tsang AK; Chan SK; Lam CC; Lui PC; Chau HH; Tan PH; Tse GM
    Histopathology; 2011 Oct; 59(4):600-8. PubMed ID: 21916949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
    Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
    J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
    Ibrahim WS
    Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
    Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
    Maritz RM; Michelow PM
    Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroepithelial tumours of the breast-a review.
    Lerwill MF; Lee AHS; Tan PH
    Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
    Moore T; Lee AH
    Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD10+ stromal cells in fibroadenomas and phyllodes tumors of the breast.
    Zamecnik M; Kinkor Z; Chlumska A
    Virchows Arch; 2006 Jun; 448(6):871-2. PubMed ID: 16550395
    [No Abstract]   [Full Text] [Related]  

  • 16. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytologic features of fibroepithelial lesions of the breast.
    Deen SA; McKee GT; Kissin MW
    Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
    Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
    Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
    Tsai WC; Jin JS; Yu JC; Sheu LF
    Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
    Kocová L; Skálová A; Fakan F; Rousarová M
    Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.